These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 14512313)

  • 21. Photochemical treatment of donor lymphocytes inhibited their ability to facilitate donor engraftment or increase donor chimerism after nonmyeloablative conditioning or establishment of mixed chimerism.
    Johnson BD; Taylor PA; Stankowski MC; Talib S; Hearst JE; Blazar BR
    Biol Blood Marrow Transplant; 2002; 8(11):581-7. PubMed ID: 12463476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pentostatin plus cyclophosphamide nonmyeloablative regimen induces durable host T cell functional deficits and prevents murine marrow allograft rejection.
    Mariotti J; Taylor J; Massey PR; Ryan K; Foley J; Buxhoeveden N; Felizardo TC; Amarnath S; Mossoba ME; Fowler DH
    Biol Blood Marrow Transplant; 2011 May; 17(5):620-31. PubMed ID: 21130889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.
    Dey BR; McAfee S; Colby C; Sackstein R; Saidman S; Tarbell N; Sachs DH; Sykes M; Spitzer TR
    Biol Blood Marrow Transplant; 2003 May; 9(5):320-9. PubMed ID: 12766882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A synthetic CD4-CDR3 peptide analog enhances bone marrow engraftment across major histocompatibility barriers.
    Koch U; Korngold R
    Blood; 1997 Apr; 89(8):2880-90. PubMed ID: 9108408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen.
    Manilay JO; Pearson DA; Sergio JJ; Swenson KG; Sykes M
    Transplantation; 1998 Jul; 66(1):96-102. PubMed ID: 9679828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD; Pham S; Li S; Aitouche A
    Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
    Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
    Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease.
    Johnson BD; Truitt RL
    Blood; 1995 Jun; 85(11):3302-12. PubMed ID: 7756664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recipient lymphocyte infusion in MHC-matched bone marrow chimeras induces a limited lymphohematopoietic host-versus-graft reactivity but a significant antileukemic effect mediated by CD8+ T cells and natural killer cells.
    De Somer L; Sprangers B; Fevery S; Rutgeerts O; Lenaerts C; Boon L; Waer M; Billiau AD
    Haematologica; 2011 Mar; 96(3):424-31. PubMed ID: 21109687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
    Hayashi H; LeGuern C; Sachs DH; Sykes M
    Bone Marrow Transplant; 1996 Aug; 18(2):285-92. PubMed ID: 8864436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
    Ito H; Kurtz J; Shaffer J; Sykes M
    J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune Reconstitution Kinetics following Intentionally Induced Mixed Chimerism by Nonmyeloablative Transplantation.
    Kim N; Lee H; Shin J; Nam YS; Im KI; Lim JY; Lee ES; Kang YN; Park SH; Cho SG
    PLoS One; 2015; 10(5):e0126318. PubMed ID: 25961559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
    Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
    Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
    Martin PJ
    J Exp Med; 1993 Aug; 178(2):703-12. PubMed ID: 8101864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of indirect allo- and autoreactivity in anti-tumor responses induced by recipient leukocyte infusions (RLI) in mixed chimeras prepared with nonmyeloablative conditioning.
    Rubio MT; Zhao G; Buchli J; Chittenden M; Sykes M
    Clin Immunol; 2006 Jul; 120(1):33-44. PubMed ID: 16675304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation.
    Truitt RL; Atasoylu AA
    Blood; 1991 Jun; 77(11):2515-23. PubMed ID: 2039833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific immunosuppression by mixed chimerism with bone marrow transplantation after Staphylococcal Enterotoxin B pretreatment could prolong corneal allograft survival in mice.
    Zhang Y; Pan Z; Chen Y; Jie Y; He Y
    Mol Vis; 2012; 18():974-82. PubMed ID: 22550390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of tolerance by mixed chimerism with nonmyeloblative host conditioning: the importance of overcoming intrathymic alloresistance.
    Nikolic B; Khan A; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(3):144-53. PubMed ID: 11302548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Ex Vivo-Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques.
    Duran-Struuck R; Sondermeijer HP; Bühler L; Alonso-Guallart P; Zitsman J; Kato Y; Wu A; McMurchy AN; Woodland D; Griesemer A; Martinez M; Boskovic S; Kawai T; Cosimi AB; Yang YG; Hu Z; Wuu CS; Slate A; Mapara M; Baker S; Tokarz R; D'Agati V; Hammer S; Pereira M; Lipkin WI; Wekerle T; Levings M; Sykes M
    Transplantation; 2017 Feb; 101(2):274-283. PubMed ID: 27846155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.